Literature DB >> 10507526

Schizophrenia and bipolar disorder: findings from studies of the Stanley Foundation Brain Collection.

M B Knable1.   

Abstract

The Stanley Foundation Brain Collection contains a matched set of specimens from patients diagnosed with schizophrenia, bipolar disorder, non-psychotic depression and normal controls. Specimens have been shipped to investigators in more than 50 laboratories around the world. To date, results obtained from studies with this collection indicate that schizophrenia and bipolar disorder may both be characterized by abnormalities in frontal cortical interneurons, although different subpopulations of these neurons may be specifically affected in the two disorders. In samples from patients with familial bipolar disorder and major depression, there are alterations in glial density in cingulate cortex. Specific effects of antidepressant drugs on the transcription factor cAMP regulatory element binding protein and brain-derived neurotrophic factor have also been observed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10507526     DOI: 10.1016/s0920-9964(99)00114-0

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  10 in total

1.  Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders.

Authors:  E A Thomas; B Dean; G Pavey; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Neuron somal size is decreased in the lateral amygdalar nucleus of subjects with bipolar disorder.

Authors:  Yarema B Bezchlibnyk; Xiujun Sun; Jun-Feng Wang; Glenda M MacQueen; Bruce S McEwen; L Trevor Young
Journal:  J Psychiatry Neurosci       Date:  2007-05       Impact factor: 6.186

3.  Evaluation of tissue collection for postmortem studies of bipolar disorder.

Authors:  Amy Deep-Soboslay; Bianca Iglesias; Thomas M Hyde; Llewelyn B Bigelow; Vesna Imamovic; Mary M Herman; Joel E Kleinman
Journal:  Bipolar Disord       Date:  2008-11       Impact factor: 6.744

4.  Alternative complement pathway in schizophrenia.

Authors:  Anna Boyajyan; Aren Khoyetsyan; Andranik Chavushyan
Journal:  Neurochem Res       Date:  2010-01-26       Impact factor: 3.996

5.  A form of DISC1 enriched in nucleus: altered subcellular distribution in orbitofrontal cortex in psychosis and substance/alcohol abuse.

Authors:  Naoya Sawamura; Takako Sawamura-Yamamoto; Yuji Ozeki; Christopher A Ross; Akira Sawa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-18       Impact factor: 11.205

Review 6.  The neurobiology of apolipoproteins in psychiatric disorders.

Authors:  J Gregor Sutcliffe; Elizabeth A Thomas
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.590

7.  Interneurons in the developing human neocortex.

Authors:  Nada Zecevic; Frances Hu; Igor Jakovcevski
Journal:  Dev Neurobiol       Date:  2011-01-01       Impact factor: 3.964

8.  DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia.

Authors:  Ned Buttner; Sujoy Bhattacharyya; John Walsh; Francine M Benes
Journal:  Schizophr Res       Date:  2007-04-17       Impact factor: 4.939

9.  Expression of POU-domain transcription factor, Oct-6, in schizophrenia, bipolar disorder and major depression.

Authors:  Kirenjeet Ubhi; Jack Price
Journal:  BMC Psychiatry       Date:  2005-10-24       Impact factor: 3.630

10.  N-Methyl D-Aspartate Receptor Antagonist Kynurenic Acid Affects Human Cortical Development.

Authors:  Inseyah Bagasrawala; Nada Zecevic; Nevena V Radonjić
Journal:  Front Neurosci       Date:  2016-09-30       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.